Advanced breast cancer consensus and the latest on triple negative breast cancer
4 Apr 2012
Advanced breast cancer consensus and the latest on triple negative breast cancer
ECCO and cancer care in Europe
Recent advances in multiple myeloma therapy
Recent advances in non-Hodgkin’s lymphoma therapy
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS)
Tips and tricks in triple-negative breast cancer
Treatment of breast cancer as a chronic disease
The role of genomic testing in personalised medicine for breast cancer
New approach to electronic health records